Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18716 | 26983477 | Zhonghua Gan Zang Bing Za Zhi | [Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan]. | 2016 | Details |
| A18718 | 26983475 | Zhonghua Gan Zang Bing Za Zhi | [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis]. | 2016 | Details |
| A18721 | 26983472 | Zhonghua Gan Zang Bing Za Zhi | [New advances in diagnosis of nonalcoholic fatty liver disease]. | 2016 | Details |
| A18723 | 26983396 | Int J Food Sci Nutr | Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study. | 2016 | Details |
| A18724 | 26981929 | Free Radic Res | Cu,Zn-SOD deficiency induces the accumulation of hepatic collagen. | 2016 | Details |
| A18728 | 26980302 | Toxicol Sci | Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis. | 2016 | Details |
| A18730 | 26980160 | Annu Rev Pathol | Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. | 2016 | Details |
| A18731 | 26980020 | Hum Pathol | Acidophil bodies in nonalcoholic steatohepatitis. | 2016 | Details |
| A18733 | 26979540 | Magn Reson Imaging | Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. | 2016 | Details |
| A18735 | 26978356 | Int J Mol Sci | Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. | 2016 | Details |
| A18737 | 26977758 | Am J Gastroenterol | The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18741 | 26976710 | Endocrinol Nutr | Effect of incretin therapies compared to pioglitazone and gliclazide in non-alcoholic fatty liver disease in diabetic patients not controlled on metformin alone: An observational, pilot study. | 2016 | Details |
| A18748 | 26972222 | Metabolism | Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet? | 2016 | Details |
| A18752 | 26971824 | Gastroenterology | Perspectives on Treatment for Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18756 | 26969270 | BMC Res Notes | Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists. | 2016 | Details |
| A18758 | 26968211 | Am J Physiol Gastrointest Liver Physiol | Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. | 2016 | Details |
| A18762 | 26962021 | Biochim Biophys Acta | Nuclear receptors and nonalcoholic fatty liver disease. | 2016 | Details |
| A18763 | 26961580 | Metabolism | Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. | 2016 | Details |
| A18764 | 26960729 | Abdom Radiol (NY) | Comparison of Doppler ultrasound and transient elastography in the diagnosis of significant fibrosis in patients with nonalcoholic steatohepatitis. | 2016 | Details |
| A18768 | 26957957 | Afr Health Sci | Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis. | 2015 | Details |
| A18780 | 26946784 | Nihon Arukoru Yakubutsu Igakkai Zasshi | [Diagnostic accuracy for alcoholic liver disease with controlled Attenuation Parameter (CAP) measured by transient elastography for the non-invasive assessment of liver steatosis]. | 2015 | Details |
| A18781 | 26946071 | J Gastroenterol Hepatol | Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients. | 2016 | Details |
| A18783 | 26945479 | Liver Int | Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects. | 2016 | Details |
| A18784 | 26944023 | Contemp Clin Trials | Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design. | 2016 | Details |
| A18785 | 26942734 | Dig Dis Sci | Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18796 | 26935501 | Adv Clin Exp Med | 13C-Methacetin Breath Testing in Patients with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18811 | 26925881 | Am J Gastroenterol | Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18812 | 26924554 | BMC Gastroenterol | Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology. | 2016 | Details |
| A18813 | 26924542 | J Autoimmun | Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model. | 2016 | Details |
| A18816 | 26923972 | Clin Calcium | [Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition]. | 2016 | Details |
| A18821 | 26921205 | Adv Ther | The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. | 2016 | Details |
| A18824 | 26919573 | Hepatology | A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. | 2016 | Details |
| A18828 | 26915720 | Gen Physiol Biophys | Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet. | 2016 | Details |
| A18833 | 26912150 | Diabetes Metab J | Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis. | 2016 | Details |
| A18834 | 26911834 | Sci Rep | Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis. | 2016 | Details |
| A18842 | 26907882 | Nat Rev Gastroenterol Hepatol | Management of NAFLD: a stage-based approach. | 2016 | Details |
| A18843 | 26907206 | Metabolism | Nonalcoholic fatty liver disease and hepatocellular carcinoma. | 2016 | Details |
| A18845 | 26905872 | PLoS One | Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score. | 2016 | Details |
| A18854 | 26900273 | J Clin Exp Hepatol | Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver Fibrosis. | 2015 | Details |
| A18857 | 26898658 | Dig Dis Sci | Gut Microbiota of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18861 | 26895659 | J Nutr Biochem | Nutritional therapy for nonalcoholic fatty liver disease. | 2015 | Details |
| A18862 | 26895403 | J Laparoendosc Adv Surg Tech A | Preliminary Evaluation of Acoustic Radiation Force Impulse Shear Wave Imaging to Detect Hepatic Fibrosis in Morbidly Obese Patients Before Bariatric Surgery. | 2016 | Details |
| A18865 | 26894897 | Cell Mol Life Sci | Pathogenesis of nonalcoholic steatohepatitis. | 2016 | Details |
| A18868 | 26893835 | Biomed Rep | Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes. | 2016 | Details |
| A18871 | 26892520 | Metabolism | Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study. | 2015 | Details |
| A18875 | 26890135 | Cell Death Dis | Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease. | 2016 | Details |
| A18893 | 26881746 | PLoS One | Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. | 2016 | Details |
| A18897 | 26881024 | Oxid Med Cell Longev | Ion Channels and Oxidative Stress as a Potential Link for the Diagnosis or Treatment of Liver Diseases. | 2016 | Details |
| A18899 | 26880657 | Obesity (Silver Spring) | The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity. | 2016 | Details |
| A18900 | 26880573 | J Hepatobiliary Pancreat Sci | Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease. | 2016 | Details |
| A18903 | 26878184 | Pediatr Ann | Nonalcoholic Fatty Liver Disease in Pediatrics. | 2016 | Details |
| A18906 | 26875698 | J Gastroenterol Hepatol | Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease. | 2016 | Details |
| A18908 | 26874689 | Dig Dis Sci | Histological Assessment of NAFLD. | 2016 | Details |
| A18909 | 26874076 | Gastroenterology | Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening. | 2016 | Details |
| A18913 | 26872443 | Nucl Med Biol | Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. | 2015 | Details |
| A18919 | 26870934 | Semin Liver Dis | Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18920 | 26870930 | Semin Liver Dis | Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18938 | 26859594 | Neuro Endocrinol Lett | Enhanced liver fibrosis (ELF) test in obese children with ultrasound-proven liver steatosis. | 2015 | Details |
| A18940 | 26858440 | Proc Natl Acad Sci U S A | Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver disease. | 2016 | Details |
| A18943 | 26857750 | Sci Rep | Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. | 2016 | Details |
| A18947 | 26856334 | Inflamm Res | TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment. | 2016 | Details |
| A18948 | 26855692 | World J Hepatol | Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. | 2016 | Details |
| A18951 | 26853695 | Hepatol Res | Association of coronary artery calcification with liver fibrosis in Japanese patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A18954 | 26852185 | Br J Clin Pharmacol | The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease. | 2016 | Details |
| A18956 | 26850495 | Gastroenterology | The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. | 2016 | Details |
| A18959 | 26849287 | Hepatology | Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention. | 2016 | Details |
| A18960 | 26848588 | Dig Dis Sci | Quantitative Imaging Biomarkers of NAFLD. | 2016 | Details |
| A18961 | 26847547 | Rev Endocr Metab Disord | The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). | 2016 | Details |
| A18977 | 26838182 | Food Funct | Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice. | 2016 | Details |
| A18978 | 26835904 | J Pediatr Gastroenterol Nutr | Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18983 | 26832365 | Lipids Health Dis | Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study. | 2016 | Details |
| A18986 | 26831610 | Saudi J Gastroenterol | Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial. | 2017 | Details |
| A18994 | 26826811 | Pak J Pharm Sci | Counter effects of N. Sativa L. and P. ovate L. on indicative markers of non alcoholic fatty liver disease. | 2016 | Details |
| A19000 | 26825843 | Dig Dis Sci | Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. | 2016 | Details |
| A19001 | 26825546 | Eur J Pharmacol | Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression. | 2016 | Details |
| A19006 | 26823198 | Metabolism | The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A19007 | 26822232 | Hepatology | Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes. | 2016 | Details |
| A19008 | 26821176 | J Med Ultrason (2001) | Relationship between liver tissue stiffness and histopathological findings analyzed by shear wave elastography and compression testing in rats with non-alcoholic steatohepatitis. | 2016 | Details |
| A19013 | 26819197 | Sci Transl Med | The intersection of nonalcoholic fatty liver disease and obesity. | 2016 | Details |
| A19020 | 26817117 | Eksp Klin Gastroenterol | [COMPARISON OF DIFFERENT TREATMENT REGIMENS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE]. | 2015 | Details |
| A19021 | 26815314 | Liver Int | Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. | 2016 | Details |
| A19034 | 26810159 | Diabetes Metab Syndr | Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes. | 2016 | Details |
| A19037 | 26808140 | PLoS One | Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study. | 2016 | Details |
| A19040 | 26807382 | J Clin Transl Hepatol | TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19048 | 26803754 | Obes Surg | The Correlation Between Obesity-Related Diseases and Non-alcoholic Fatty Liver Disease in Women in the Pre-operative Evaluation for Bariatric Surgery Assessed by Transient Hepatic Elastography. | 2016 | Details |
| A19050 | 26803355 | Diabetes Res Clin Pract | Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide. | 2016 | Details |
| A19055 | 26797396 | Am J Physiol Gastrointest Liver Physiol | Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice. | 2016 | Details |
| A19057 | 26794269 | Nat Rev Drug Discov | Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. | 2016 | Details |
| A19064 | 26787197 | Obes Surg | Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients. | 2016 | Details |
| A19066 | 26786607 | Sao Paulo Med J | Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study. | 2016 | Details |
| A19068 | 26785389 | Hepatol Res | The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. | 2016 | Details |
| A19073 | 26783552 | Cell Mol Gastroenterol Hepatol | Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ. | 2015 | Details |
| A19082 | 26775559 | Metabolism | Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2015 | Details |
| A19088 | 26773297 | Hepatology | Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2016 | Details |
| A19090 | 26771611 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation. | 2016 | Details |
| A19098 | 26770272 | Therap Adv Gastroenterol | Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis. | 2016 | Details |
| A19101 | 26768633 | Adv Clin Exp Med | The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test. | 2016 | Details |
| A19102 | 26765961 | Aliment Pharmacol Ther | I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders. | 2016 | Details |
| A19103 | 26764184 | Gastroenterology | Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. | 2016 | Details |
| A19105 | 26763834 | Hepatol Res | Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study. | 2016 | Details |